Lupin Digital Health, American College of Cardiology Partners to Deliver in-home Cardiovascular Care

India Pharma Outlook Team | Tuesday, 25 July 2023

 India Pharma Outlook Team

Lupin Digital Health and the American College of Cardiology (ACC) today announced a groundbreaking collaboration to provide in-home cardiovascular care in India using Digital Therapeutics (DTx). The goal of this collaboration is to hasten the implementation and adoption of DTx in cardiology in India. Lyfe, Lupin Digital Health's DTx platform, also intends to empower patients and their healthcare providers with tools to manage heart disorders at home, as well as to assist patients stay healthy following hospital release and avoid rehospitalization.

Lupin Digital Health will use ACC's CardioSmart platform, guidelines, and workbooks to help healthcare professionals and carers as part of this collaboration. Doctors, patients, and carers will have access to these capabilities via Lupin Digital Health's Lyfe app and website. "This collaboration with Lupin Digital Health reflects our commitment to advancing equitable cardiovascular care globally and demonstrates how innovative collaborations can deliver transformative outcomes for patients in India," ACC Chief Innovation Officer Ami B Bhatt said. "India's vast talent pool and widespread adoption of smartphone-based technology provide enormous opportunity for leveraging Digital Therapeutics." Our primary goal is to develop practical solutions that enable doctors to provide improved patient care.

"Through our collaboration with ACC, we hope to revolutionise the management of heart disease in India by enabling healthcare professionals and carers to provide effective care to patients outside of hospitals," said Rajeev Sibal, President of Lupin Limited's India Region Formulations. Emphasising the patient-centric approach of the collaboration, Sidharth Srinivasan, CEO, Lupin Digital Health, said, "The mounting burden of cardiovascular disease in India, affecting even the younger generation, makes this collaboration an urgent imperative.” To promote the adoption of advanced digital solutions in cardiology, ACC will provide certificates to cardiologists, recognising their dedication to innovation and patient-centric healthcare. This collaboration plays a pivotal part in ensuring optimal care and driving improved outcomes within the comfort of patients’ homes.

© 2024 India Pharma Outlook. All Rights Reserved.